The Cancer Letter

The leading source for information on the issues that shape oncology since 1973

Funding Opportunities

CDMRP announces rare cancers research program funding opportunities for FY25

Share on facebook
Share on twitter
Share on linkedin
Share on email
Share on print
BYLINE
IN THIS ISSUE
DOWNLOAD PDFTABLE OF CONTENTS

The Full-Year Continuing Appropriations and Extensions Act of 2025 provides $650 million in funding for the Congressionally Directed Medical Research Programs (The Cancer Letter, March 28, 2025). Congress provided further guidance for CDMRP program-level funding, including funding for the Rare Cancers Research Program. 

To access this subscriber-only content please log in or subscribe.

If your institution has a site license, log in with IP-login or register for a sponsored account.*
*Not all site licenses are enrolled in sponsored accounts.

Login Subscribe
Table of Contents

YOU MAY BE INTERESTED IN

In Brief

Northwestern Mutual to support childhood cancer survivors, siblings with $500,000 in college scholarships

Northwestern Mutual, through its Foundation, announced a class of scholars from its annual Childhood Cancer Scholarship Program for families affected by childhood cancer. The program provides scholarships to students affected by a diagnosis—either as survivors themselves or as siblings—enabling recipients to chase their dreams and transform their experience into purpose.
Table of Contents

Never miss an issue!

Get alerts for our award-winning coverage in your inbox.

Login

Site license subscribers:
Log in with your IP | Register a sponsored account